Pharmacological activity of peroral chitosan-insulin nanoparticles in diabetic rats.
暂无分享,去创建一个
Tit Meng Lim | T. Lim | L. Lim | Lee-Yong Lim | Zengshuan Ma | Zengshuan Ma
[1] Akira Yamamoto,et al. Penetration and enzymatic barriers to peptide and protein absorption , 1989 .
[2] P. Artursson,et al. Chitosans as Absorption Enhancers for Poorly Absorbable Drugs 2: Mechanism of Absorption Enhancement , 1997, Pharmaceutical Research.
[3] Sek-Man Wong,et al. The degree of deacetylation of chitosan: advocating the first derivative UV-spectrophotometry method of determination. , 1998, Talanta.
[4] N. Gallo‐Payet,et al. Insulin receptors in isolated adult mouse intestinal cells: studies in vivo and in organ culture. , 1984, Endocrinology.
[5] P. Couvreur,et al. New Approach for Oral Administration of Insulin With Polyalkylcyanoacrylate Nanocapsules as Drug Carrier , 1988, Diabetes.
[6] Min Huang,et al. Uptake of FITC-Chitosan Nanoparticles by A549 Cells , 2002, Pharmaceutical Research.
[7] E. Mathiowitz,et al. Nanosphere based oral insulin delivery. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[8] P. Couvreur,et al. Insulin‐loaded nanocapsules for oral administration: In vitro and in vivo investigation , 2000 .
[9] Hui Xu,et al. Bioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the intestinal absorption of insulin in vivo. , 2002, International journal of pharmaceutics.
[10] P. Lowe,et al. Calcitonin and Insulin in Isobutylcyanoacrylate Nanocapsules: Protection Against Proteases and Effect on Intestinal Absorption in Rats , 1994, The Journal of pharmacy and pharmacology.
[11] H. Junginger,et al. Chitosans for enhanced delivery of therapeutic peptides across intestinal epithelia: in vitro evaluation in Caco-2 cell monolayers , 1997 .
[12] M. Morishita,et al. Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method. , 1999, Drug development and industrial pharmacy.
[13] H. Junginger,et al. Mucoadhesive polymers in peroral peptide drug delivery. IV. Polycarbophil and chitosan are potent enhancers of peptide transport across intestinal mucosae in vitro , 1997 .
[14] C. Remuñán-López,et al. Enhancement of Nasal Absorption of Insulin Using Chitosan Nanoparticles , 1999, Pharmaceutical Research.
[15] S. Bo,et al. Determination of the Mark-Houwink equation for chitosans with different degrees of deacetylation. , 1991, International journal of biological macromolecules.
[16] A. Jamal,et al. Regulation of mucosal phosphofructokinase in the small intestine of the streptozotocin-diabetic rat , 1983, Diabetologia.
[17] Per Artursson,et al. Chitosans as Absorption Enhancers for Poorly Absorbable Drugs. 1: Influence of Molecular Weight and Degree of Acetylation on Drug Transport Across Human Intestinal Epithelial (Caco-2) Cells , 1996, Pharmaceutical Research.
[18] Donald E. Chickering,et al. Biologically erodable microspheres as potential oral drug delivery systems , 1997, Nature.
[19] Claus-Michael Lehr,et al. In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers , 1992 .
[20] Lisbeth Illum,et al. Chitosan as a Novel Nasal Delivery System for Peptide Drugs , 1994, Pharmaceutical Research.
[21] L. Lim,et al. Formulation pH modulates the interaction of insulin with chitosan nanoparticles. , 2002, Journal of pharmaceutical sciences.
[22] T. Csáky,et al. Intestinal Sugar Transport in Experimental Diabetes , 1981, Diabetes.